Cargando…
Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance
BACKGROUND: Immune checkpoint blockade (ICB) therapy has revolutionized the treatment of lung squamous cell carcinoma (LUSC). However, a significant proportion of patients with high tumour PD-L1 expression remain resistant to immune checkpoint inhibitors. To understand the underlying resistance mech...
Autores principales: | Yang, Minglei, Lin, Chenghao, Wang, Yanni, Chen, Kang, Zhang, Haiyue, Li, Weizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264601/ https://www.ncbi.nlm.nih.gov/pubmed/35799269 http://dx.doi.org/10.1186/s13073-022-01079-x |
Ejemplares similares
-
Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis
por: Yang, Minglei, et al.
Publicado: (2022) -
Multi-omic analysis characterizes molecular susceptibility of receptors to SARS-CoV-2 spike protein
por: Wu, Fanjie, et al.
Publicado: (2023) -
S100A7 attenuates immunotherapy by enhancing immunosuppressive tumor microenvironment in lung squamous cell carcinoma
por: Liu, Chengming, et al.
Publicado: (2022) -
Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
por: Li, Hongmu, et al.
Publicado: (2023) -
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
por: Giles, Amber J., et al.
Publicado: (2018)